Raltegravir
Isentress, Isentress Hd (raltegravir) is a small molecule pharmaceutical. Raltegravir was first approved as Isentress on 2007-10-12. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Isentress's patents are valid until 2032-03-30 (FDA).
| Trade Name | Isentress |
|---|---|
| Common Name | Raltegravir |
| Indication | hiv infections |
| Drug Class | Antivirals: integrase inhibitors |
